You are here

  • Home
  • Archive
  • Volume 68, Issue 8
  • Dihydroorotate dehydrogenase polymorphism influences the toxicity of leflunomide treatment in patients with rheumatoid arthritis

Article Text

Article menu
Download PDFPDF
Letter
Dihydroorotate dehydrogenase polymorphism influences the toxicity of leflunomide treatment in patients with rheumatoid arthritis

https://doi.org/10.1136/ard.2008.099093

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Footnotes

    • Competing interests: None.

    • Funding: This work was financially supported by the Slovenian Research Agency, grant No PO-0503-0381.

    • Ethics approval: Approval from the National Medical Ethics Committee, Republic of Slovenia.